2019 tables: Institutions - Nature & Science - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share 2017-2018*
1 F. Hoffmann-La Roche AG, Switzerland 2.24 5.01 13 109.1%
2 Alphabet Inc., United States of America (USA) 2.20 4.88 9 106.4%
3 Merck & Co., Inc., United States of America (USA) 3.67 4.43 8 12.6%
4 IBM Corporation, United States of America (USA) 3.02 4.16 10 28.5%
5 Novartis International AG, Switzerland 3.80 1.93 8 -52.7%
6 D-Wave Systems, Inc., Canada 1.92 2 N/A
7 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 0.67 1.83 8 154.7%
8 Pfizer Inc., United States of America (USA) 0.11 1.48 5 1,169.9%
9 Amgen Inc., United States of America (USA) 0.90 1.38 7 42.3%
10 Toshiba Corporation, Japan 1.00 1 N/A
10 Sosei Co., Ltd., Japan 1.46 1.00 1 -36.3%
11 Bristol-Myers Squibb (BMS), United States of America (USA) 1.22 0.93 5 -28.3%
12 Johnson & Johnson, United States of America (USA) 0.84 0.69 4 -24.3%
13 Samsung Group, South Korea 0.57 0.63 5 3.0%
14 Intel Corporation, United States of America (USA) 0.17 0.60 1 235.5%
15 AstraZeneca plc, United Kingdom (UK) 0.39 0.55 3 30.5%
16 BGI, China 0.85 0.52 4 -43.1%
17 Novome Biotechnologies, Inc., United States of America (USA) 0.50 1 N/A
18 Anglo American plc, United Kingdom (UK) 0.26 0.48 2 70.7%
19 Nokia Corporation, Finland 0.46 2 N/A
20 Genmab B.V., Netherlands 0.41 1 N/A
21 Saint-Gobain SA, France 0.38 2 N/A
22 MyHeritage, Israel 0.36 2 N/A
23 Illumina, Inc., United States of America (USA) 0.10 0.35 4 210.9%
24 Agios Pharmaceuticals, Inc., United States of America (USA) 0.29 0.34 2 7.5%
25 BioNano Genomics, United States of America (USA) 0.13 0.33 3 128.4%
26 Thinkcyte Inc., Japan 0.32 1 N/A
27 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 0.31 2 N/A
28 Nippon Telegraph and Telephone Corporation (NTT), Japan 0.31 3 N/A
29 Eisai Co., Ltd., Japan 0.31 1 N/A
29 D. E. Shaw Research, United States of America (USA) 0.31 1 N/A
30 Leidos Holdings, Inc., United States of America (USA) 0.32 0.31 4 -10.0%
31 Immatics Biotechnologies GmbH, Germany 0.30 1 N/A
32 Gilead Sciences, Inc., United States of America (USA) 0.30 2 N/A
33 New England Biolabs, Inc. (NEB), United States of America (USA) 1.00 0.29 1 -72.6%
34 Royal Dutch Shell plc (Shell), Netherlands 0.27 1 N/A
35 Asymchem Labs., China 0.23 0.27 1 7.7%
36 Atmospheric and Environmental Research, Inc. (AER), United States of America (USA) 0.25 1 N/A
36 Argenx SE, Belgium 0.25 1 N/A
37 AIT Austrian Institute of Technology GmbH, Austria 0.08 0.25 4 175.9%
38 Honda Motor Co., Ltd., Japan 0.24 1 N/A
39 Wuhan Frasergen Bioinformatics Co., Ltd., China 0.24 1 N/A
40 Integral Molecular, Inc., United States of America (USA) 0.21 1 N/A
41 TES Pharma S.r.l., Italy 0.21 1 N/A
42 ExpreS2ion Biotechnologies Aps, Denmark 0.19 1 N/A
43 E. I. du Pont de Nemours and Company (DuPont), United States of America (USA) 0.01 0.19 3 3,057.8%
44 WuXi AppTec, China 0.18 2 N/A
45 UCB S.A., Belgium 0.18 1 N/A
46 Puma Biotechnology, Inc., United States of America (USA) 0.17 1 N/A
47 China Shipbuilding Industry Corporation (CSIC), China 0.03 0.16 4 390.5%
48 LG Corporation, South Korea 0.15 1 N/A
48 Shimadzu Corporation, Japan 0.15 1 N/A
49 Chengdu Institute of Organic Chemistry (CIOC), CAS, China 0.15 1 N/A
50 BASF SE, Germany 0.15 3 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.